Murlentamab (Anti-AMHR2)

Murlentamab (Anti-AMHR2) is a humanized anti-AMHRII antibody targeting AMHRII. It suppresses tumor growth, stimulates the anti-tumor adaptive immune response through naive macrophage orientation and TAM reprogrammation, in ovarian tumor cells. MW :145.5 KD.
Supplier Selleck Chemicals
Product # A2590
Sku # A2590-1mg
Pricing 1mg, $370.00
Feedback